Finally, the presence of this splice variant in tissues at 3 dpi, when the response to infection is winding down, is consistent with the hypothesis that the splice variant functions as a dominant inhibitor of full length RIG-I to prevent MAVS activation, as demonstrated for the human RIG-I splice variant [37]. This evidence concerns the gene MAVS and infection.